NIH National Cancer Institute (NCI), as the leader of the National Cancer Program, supports and conducts ground breaking research in cancer biology, causation, prevention, detection, treatment, and survivorship in its effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families. visit http: & & cancer. gov ...
VIDA Diagnostics provides software and analysis services that aid in the early detection, evaluation and treatment planning of lung diseases, including lung cancer, emphysema, airway obstructive diseases and asthma ...
reliable, fast and affordable authentication and identification of human cancer lines, stem cell lines, as well as xenografts; human specimens using STR profiling, includes a mouse marker for detection of mouse DNA. Mycoplasma contamination detection, HLA testing and MSI testing are among other services also available ...
Quality Discovery & Development programs and innovative Platforms, including; Cancer & Cancer Immunology studies with pharmacodynamic endpoints; Advanced PDX models, Rapid, sensitive CTC Analysis, Target Specific Antibody Detection, Platform delivering macromolecules intracellularly. Collaborative Drug Discovery and Development Programs for biologics and small molecules leveraging SRI’s experience and expertise ...
Medocity's continuous care platform enables organizations to deliver comprehensive care between visits for patients with chronic and high risk, complex conditions cancer, heart failure, diabetes, COPD, depression, Advanced technology and clinical algorithms provide real time monitoring RPM, early detection, proactive interventions and televisits to prevent escalation of patient reported symptoms, drive higher ...
World recognized for Quality, Accuracy & Reliability, Hemosure's one step iFOB Test FIT is dedicated to early detection of Colo Rectal Cancer ...
Asthma, Copd, Airway Diseases; Copd; VIDA is focused on changing the practice of pulmonary care by empowering the pulmonary clinician with precision informatics. VIDA’s suite of software and associated analysis services aid early detection, evaluation, and treatment planning of lung diseases, including lung cancer, emphysema, airway obstructive diseases, and asthma. VIDA’s software and services are cleared for ...